CLINICAL_TRIALS
trial_result
· 2022-01-24
Clinical Trial Update: Etokimab in Adults With Chronic Rhinosinusitis With Nasal Polyps (CRSwNP) [Phase 2]
Summary
Phase 2 clinical trial of etokimab in adults with chronic rhinosinusitis with nasal polyps has completed; results posted in 2022.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: AnaptysBio, Inc. | Conditions: Chronic Rhinosinusitis | Phase 2 | Status: COMPLETED | Results posted: 2022-01-24